Krebs Biochemicals & Industries Limited (KREBSBIO.NS)
INR 70.37
(-3.63%)
INR 70.37
(-3.63%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 1.83 Billion INR | 5.92% |
| 2022 | 1.73 Billion INR | 261.46% |
| 2021 | 479.3 Million INR | -52.33% |
| 2020 | 1 Billion INR | 24.89% |
| 2019 | 805.05 Million INR | -11.5% |
| 2018 | 909.61 Million INR | 4.16% |
| 2017 | 873.31 Million INR | 104.11% |
| 2016 | 427.87 Million INR | -39.78% |
| 2015 | 710.47 Million INR | 302.6% |
| 2014 | 176.47 Million INR | 0.0% |
| 2012 | 570.45 Million INR | -11.91% |
| 2011 | 647.56 Million INR | -24.83% |
| 2010 | 861.47 Million INR | -0.66% |
| 2009 | 867.23 Million INR | 4.89% |
| 2008 | 826.76 Million INR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q1 | - INR | -100.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 FY | 1.83 Billion INR | 5.92% |
| 2023 Q2 | 1.78 Billion INR | 0.0% |
| 2023 Q4 | 1.83 Billion INR | 0.0% |
| 2023 Q3 | - INR | -100.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q4 | 1.73 Billion INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2022 FY | 1.73 Billion INR | 261.46% |
| 2022 Q2 | 1.64 Billion INR | 0.0% |
| 2021 Q4 | 479.3 Million INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 FY | 479.3 Million INR | -52.33% |
| 2021 Q2 | 1.12 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2020 FY | 1 Billion INR | 24.89% |
| 2020 Q2 | 819.14 Million INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q4 | 1 Billion INR | 0.0% |
| 2019 Q4 | 805.05 Million INR | 0.0% |
| 2019 FY | 805.05 Million INR | -11.5% |
| 2019 Q2 | 512.27 Million INR | 0.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q1 | - INR | -100.0% |
| 2018 Q2 | 509.5 Million INR | -1.86% |
| 2018 Q1 | 519.18 Million INR | 0.5% |
| 2018 FY | 909.61 Million INR | 4.16% |
| 2018 Q4 | 909.61 Million INR | 0.0% |
| 2018 Q3 | - INR | -100.0% |
| 2017 Q2 | 514.44 Million INR | 0.0% |
| 2017 Q4 | 516.61 Million INR | 0.0% |
| 2017 Q1 | - INR | -100.0% |
| 2017 FY | 873.31 Million INR | 104.11% |
| 2017 Q3 | - INR | -100.0% |
| 2016 Q4 | 427.87 Million INR | 0.0% |
| 2016 FY | 427.87 Million INR | -39.78% |
| 2016 Q3 | - INR | -100.0% |
| 2016 Q2 | 794.24 Million INR | 0.0% |
| 2016 Q1 | - INR | -100.0% |
| 2015 Q1 | - INR | -100.0% |
| 2015 FY | 710.47 Million INR | 302.6% |
| 2015 Q4 | 710.47 Million INR | 0.0% |
| 2015 Q3 | - INR | -100.0% |
| 2015 Q2 | 656.47 Million INR | 0.0% |
| 2014 Q4 | 576.09 Million INR | 0.0% |
| 2014 Q1 | - INR | 0.0% |
| 2014 FY | 176.47 Million INR | 0.0% |
| 2013 Q2 | 570.45 Million INR | 0.0% |
| 2013 Q4 | - INR | -100.0% |
| 2013 Q3 | 83.48 Million INR | -85.37% |
| 2012 FY | 570.45 Million INR | -11.91% |
| 2012 Q2 | 678.17 Million INR | 0.0% |
| 2011 Q4 | 647.56 Million INR | 0.0% |
| 2011 FY | 647.56 Million INR | -24.83% |
| 2010 FY | 861.47 Million INR | -0.66% |
| 2009 FY | 867.23 Million INR | 4.89% |
| 2008 FY | 826.76 Million INR | 0.0% |
| 2008 Q4 | 826.76 Million INR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 628.8 Million INR | -191.826% |
| Bafna Pharmaceuticals Limited | 107.53 Million INR | -1606.469% |
| FDC Limited | 2.46 Million INR | -74312.003% |
| Gufic Biosciences Limited | 1.53 Billion INR | -19.184% |
| Jubilant Pharmova Limited | 31.67 Billion INR | 94.206% |
| Nectar Lifesciences Limited | 1.4 Billion INR | -30.783% |
| Orchid Pharma Limited | 1.2 Billion INR | -52.371% |
| Alkem Laboratories Limited | 400 Million INR | -358.75% |
| Bajaj HealthCare Limited | 650.34 Million INR | -182.158% |
| Brooks Laboratories Limited | 3.56 Million INR | -51372.651% |
| Eris Lifesciences Limited | 6.54 Billion INR | 71.964% |
| Glenmark Life Sciences Limited | 147.61 Million INR | -1143.141% |
| Solara Active Pharma Sciences Limited | 1.17 Billion INR | -56.25% |
| Innova Captab Limited | 2.1 Billion INR | 12.835% |
| Jagsonpal Pharmaceuticals Limited | 75.57 Million INR | -2328.212% |
| Wanbury Limited | 820 Million INR | -123.78% |
| Lupin Limited | 1.55 Billion INR | -18.174% |
| Aarti Drugs Limited | 2.75 Billion INR | 33.353% |
| Aarti Pharmalabs Limited | 400 Thousand INR | -458650.0% |
| Albert David Limited | 6.01 Million INR | -30401.995% |
| Alembic Limited | 73.9 Million INR | -2383.085% |
| Biofil Chemicals and Pharmaceuticals Limited | - INR | -Infinity% |
| Hester Biosciences Limited | 1.81 Billion INR | -0.95% |
| Hikal Limited | 4.22 Billion INR | 56.604% |
| Ind-Swift Laboratories Limited | 111.62 Million INR | -1543.882% |
| Ind-Swift Limited | 10.09 Billion INR | 81.823% |
| IOL Chemicals and Pharmaceuticals Limited | - INR | -Infinity% |
| Kilitch Drugs (India) Limited | - INR | -Infinity% |
| Lincoln Pharmaceuticals Limited | - INR | -Infinity% |
| Mangalam Drugs & Organics Limited | 133.54 Million INR | -1274.11% |
| Medico Remedies Limited | 8.67 Million INR | -21060.055% |
| Morepen Laboratories Limited | 33.64 Million INR | -5354.816% |
| Procter & Gamble Health Limited | 68.8 Million INR | -2567.151% |
| RPG Life Sciences Limited | -30.3 Million INR | 6156.106% |
| Sigachi Industries Limited | 265.79 Million INR | -590.374% |
| Sun Pharmaceutical Industries Limited | 13.3 Million INR | -13696.992% |
| Suven Pharmaceuticals Limited | 212.35 Million INR | -764.115% |
| Themis Medicare Limited | 267.74 Million INR | -585.366% |
| Unichem Laboratories Limited | 382.22 Million INR | -380.089% |
| Vaishali Pharma Limited | 35.98 Million INR | -4999.63% |
| Venus Remedies Limited | 386.8 Million INR | -374.405% |
| Windlas Biotech Limited | 20.18 Million INR | -8993.162% |
| ZIM Laboratories Limited | 356 Million INR | -415.441% |
| Sakar Healthcare Limited | 549.55 Million INR | -233.91% |
| Aurobindo Pharma Limited | 21.34 Billion INR | 91.405% |
| Divi's Laboratories Limited | 20 Million INR | -9075.0% |
| AstraZeneca Pharma India Limited | 27.83 Million INR | -6492.183% |
| Mankind Pharma Limited | 325.81 Million INR | -463.203% |
| Sequent Scientific Limited | 1.42 Billion INR | -28.574% |
| Laurus Labs Limited | 7.98 Billion INR | 77.012% |
| Neuland Laboratories Limited | 449.2 Million INR | -308.499% |
| J. B. Chemicals & Pharmaceuticals Limited | 236.4 Million INR | -676.227% |
| Glenmark Pharmaceuticals Limited | 1.51 Billion INR | -20.97% |
| Zydus Lifesciences Limited | 251 Million INR | -631.076% |
| Amrutanjan Health Care Limited | 13.96 Million INR | -13037.171% |
| Wockhardt Limited | 8.91 Billion INR | 79.405% |
| Bal Pharma Limited | 363.82 Million INR | -404.365% |
| Dr. Reddy's Laboratories Limited | 5.99 Billion INR | 69.366% |
| Bliss GVS Pharma Limited | 355.92 Million INR | -415.562% |
| Par Drugs and Chemicals Limited | - INR | -Infinity% |
| Caplin Point Laboratories Limited | 9.2 Million INR | -19845.652% |
| Shilpa Medicare Limited | 5.6 Billion INR | 67.241% |
| Valiant Laboratories Limited | 750.89 Million INR | -144.374% |
| Ajanta Pharma Limited | 235.2 Million INR | -680.187% |
| Aarey Drugs & Pharmaceuticals Limited | 32.24 Million INR | -5591.023% |
| Granules India Limited | 689.71 Million INR | -166.054% |
| Medicamen Biotech Limited | 12.55 Million INR | -14515.691% |
| Ipca Laboratories Limited | 5.8 Billion INR | 68.384% |
| Syncom Formulations (India) Limited | -1.21 Million INR | 150633.224% |
| Piramal Enterprises Limited | 535.85 Billion INR | 99.658% |
| Torrent Pharmaceuticals Limited | 16.04 Billion INR | 88.56% |
| NATCO Pharma Limited | 53 Million INR | -3362.264% |
| Suven Life Sciences Limited | - INR | -Infinity% |
| Strides Pharma Science Limited | 6.71 Billion INR | 72.673% |
| Indoco Remedies Limited | 3.51 Billion INR | 47.829% |
| Alpa Laboratories Limited | - INR | -Infinity% |
| Lasa Supergenerics Limited | - INR | -Infinity% |
| Sun Pharma Advanced Research Company Limited | 106.6 Million INR | -1621.388% |